| Open Price | 586.40 | Shares Traded | 110 |
| High Price | 586.40 | 52 Wk High | 728.80 |
| Low Price | 582.50 | 52 Wk Low | 576.00 |
| Previous Close | 580.80 | Face Value | 10.00 |
| 52 Wk High Date | - | 52 Wk Low Date | - |
| Open Price | 580.00 | Shares Traded | 1382 |
| High Price | 585.00 | 52 Wk High | 730.90 |
| Low Price | 577.25 | 52 Wk Low | 569.15 |
| Previous Close | 577.35 | Face Value | 10.00 |
| 52 Wk High Date | - | 52 Wk Low Date | - |
| Key Financials | Latest Qrtr. | Trailing Yr. | Full Yr. |
| Year End | Mar, 2012 | Mar, 2012 | Dec, 2011 |
| Sales (Rs.cr) | 136.74 | 579.05 | 557.57 |
| Net Profit (Rs.cr) | 12.39 | 62.64 | 63.65 |
| Net Profit Var (%) | -8.00 | 2.00 | 1.00 |
| EPS (Rs) | - | 38.30 | |
| P/E Ratio | - | 15.29 | 15.10 |
| Operating Profit Margin | - | 8.99 | - |
| CPS (Rs.) | - | - | 43.10 |
| P/C Ratio | - | - | 13.40 |
| Div% | - | - | - |
| Related Companies | ||
| Stock Name | Price | |
| PHARMACIAHEALTH | 132.85 | |
| ASTRAZEN | 1,895.00 | |
| BOEHRINGERMERGE | 132.00 | |
| ABBOTINDIA | 1,426.00 | |
| BURROUGHSWEL | 897.20 | |
| WYETH | 867.00 | |
| SMITHB | 123.15 | |
| FULFORD | 632.00 | |
| GLAXO | 1,974.75 | |
| NOVARTIND | 712.70 | |
| Fundamentals | |
| Market Capital (Rs.cr) | 957.99 |
| EPS (Rs.)(TTM) | |
| P/E Ratio(TTM) | 15.29 |
| Book Value (Rs.) | 247.00 |
| Price to Book Value | 2.34 |
| Equity (Rs.cr.) | 16.60 |
| Traded Value (Rs.lac) | 5.41 |
| Announcements | |
| 18-11-2010 | Merck appoints director |
| Gross Deliverables | |||||
| Date | Del. Shares | Trd. Qty. | Del.(%) | Del. Value | Turnover |
| 15-05-2012 | 3350 | 3971 | 84.36 | 1973988 | 2,325.19 |
| 11-05-2012 | 863 | 945 | 91.32 | 511155 | 561.78 |
| 09-05-2012 | 985 | 2920 | 33.73 | 584253 | 1,762.81 |
| 08-05-2012 | 1000 | 1370 | 72.99 | 593700 | 823.31 |
| 04-05-2012 | 984 | 1351 | 72.83 | 588875 | 812.55 |
